VeriMomБезопасен ли spironolactone при беременности?
Spironolactone has a harmonised CLP reproductive toxicity classification (H360 — 'May damage fertility or the unborn child') on ECHA records/annex listings, and animal and case-report data support anti‑androgenic effects on fetal sexual development; mechanism is well characterised (anti‑androgenic activity demonstrated in vivo). Topical cosmetic use would usually give low systemic exposure compared with oral therapeutic dosing, so exposure from typical topical cosmetic use is judged low but measurable. Sources: ECHA CLP/harmonised listing, FDA product label, animal/human reports (PubMed/PMC).
Безопасные альтернативы spironolactone при беременности | VeriMom
Related ingredients
Frequently asked questions
- Безопасен ли spironolactone при беременности?
- Spironolactone has a harmonised CLP reproductive toxicity classification (H360 — 'May damage fertility or the unborn child') on ECHA records/annex listings, and animal and case-report data support anti‑androgenic effects on fetal sexual development; mechanism is well characterised (anti‑androgenic activity demonstrated in vivo). Topical cosmetic use would usually give low systemic exposure compared with oral therapeutic dosing, so exposure from typical topical cosmetic use is judged low but measurable. Sources: ECHA CLP/harmonised listing, FDA product label, animal/human reports (PubMed/PMC).
- Безопасен ли spironolactone при грудном вскармливании?
- Intrinsic hazard remains at H360 level (may damage the unborn child/fertility). Mechanism (anti‑androgenic activity / endocrine effects) is well characterised. Clinical/lactation databases (LactMed, NHS) report low transfer of spironolactone into breast milk and no consistent adverse effects in reported infants at therapeutic maternal doses, so exposure to a breastfed infant from maternal systemic dosing is generally low; for cosmetic topical use systemic levels would be expected to be lower still (low but potentially measurable).
- Безопасен ли spironolactone для кожи малыша?
- The substance carries harmonised H360 (intrinsic reproductive hazard) so hazard score is 3. Mechanistic anti‑androgenic activity is well characterised. Exposure for infants (0–3 yr) is higher than adults for a given topical exposure because of immature barrier and higher surface‑area‑to‑weight; therefore exposure score is increased by one compared with adult topical use (adult topical e=1 → infant e=2). There is no infant‑specific evidence to change hazard or mechanism scores.
- Как VeriMom оценивает spironolactone?
- VeriMom оценивает spironolactone в 13/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы spironolactone при беременности?
- См. наш список безопасных альтернатив spironolactone с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.